Cognitive Control and Metacognition Training
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-11
SponsorBoston Children's Hospital
About this trial
95 autistic children (ages 8-11yrs) will be randomly assigned to a novel computer-based Cognitive Control Training combined with Metacognition Coaching or to a comparison group that receives the intervention after a delay. Before and after intervention, electroencephalography (EEG) will be used to examine engagement of the target neural responses.
Eligibility criteria
Qualifiers
Children should be 8 to 11 years of age
Children should have an existing diagnosis of an autism spectrum disorder, which will be confirmed using research measures and criteria
Children must have general cognitive ability in the average range or above (above 80 using the Wechsler Abbreviated Scale of Intelligence-2 Full Scale IQ)
Caregivers and children must be fluent in English or Spanish
Disqualifiers
Children must not have a known genetic condition related to autism (e.g., Fragile X)
Children must not have medical conditions/injuries, exposure to substances, or significant deprivation with implications for the central nervous system or that require regular psychoactive medications that alter EEG responses (anticonvulsants, barbiturates) *
Children must not have seizures or a seizure disorder (other than history of febrile seizures)
Children must not have significant sensory or motor impairment or major physical abnormalities that would limit the ability to participate in table top or EEG testing, or make responding during computer activities difficult
Trial design
Treatments tested in this trial
- Cognitive Control Training + Metacognition Coaching
Treatment groups
95 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov